Stock Taper
EXCHANGE TRADED FUND

MNTL

Tema Neuroscience And Mental Health ETF
$23.80 ▲ 0.28%
+$0.07 TODAY

FUND FACTS

Manager Tema
Assets $10.28M
Expense ratio 0.75%
Inception Jan 22, 2024
Asset class Equity
Holdings 35
Volume 133
Avg volume 83

ABOUT THIS FUND

The actively managed Tema Neuroscience and Mental Health ETF seeks to provide long-term growth of capital by investing in companies tackling diseases of the central nervous system and mental health. The fund is designed to capitalize on innovation in treatments for CNS diseases.

PRICE

$23.80 ▲ UP 48.35% (+$73.38)

No price history available for MNTL over this range.

HOLDINGS

TOP 20 OF 35 · 77.02% OF THE FUND
RANK STOCK WEIGHT SHARES VALUE
04 ARGX argenx SE 5.83% 890 $599.68K
07 LLY Eli Lilly and Company 4.05% 547 $416.99K
09 IONS Ionis Pharmaceuticals, Inc. 3.48% 8.32K $357.92K
10 SYK Stryker Corporation 3.22% 877 $331.32K
11 BIIB Biogen Inc. 3.21% 2.5K $330.01K
12 MDT Medtronic plc 2.59% 2.98K $265.88K
13 ACAD ACADIA Pharmaceuticals Inc. 2.42% 10.6K $249.32K
14 AXSM Axsome Therapeutics, Inc. 2.33% 2.33K $239.73K
15 DNLI Denali Therapeutics Inc. 1.98% 15.17K $203.94K
16 JAZZ Jazz Pharmaceuticals plc 1.88% 1.67K $193.15K
17 RNA Atrium Therapeutics, Inc. 1.88% 5.39K $193.68K
18 XENE Xenon Pharmaceuticals Inc. 1.81% 6.11K $186.38K
19 DXCM DexCom, Inc. 1.72% 2.23K $176.87K

SECTOR HOLDINGS

TECHNOLOGY IS 100.00% OF THE FUND
Healthcare 100.00%

BY REGION

UNITED STATES IS 74.62% OF THE FUND
United States 74.62%
Ireland 6.42%
Netherlands 5.83%
Israel 4.32%
Belgium 2.48%
Other 2.08%
Canada 1.81%
Germany 1.30%
Finland 1.14%